(CIDRAP News) The World Health Organization (WHO) replied at greater length today to recent criticism of the way it used science advisors in pandemic planning, defending its response to the H1N1 flu pandemic but allowing that its policies concerning transparency and relations with the pharmaceutical industry need strengthening.
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.
(CIDRAP News) Based on an assessment of outside experts, the World Health Organization (WHO) announced today that it is sticking with its current pandemic alert level, based on recurring but low-level activity in some parts of the globe and until it has more information on the Southern Hemisphere's flu season.
(CIDRAP News) A letter and commentary published this week in Emerging Infectious Diseases explore the idea that "original antigenic sin"the hypothesis that the first influenza A virus a person encounters in childhood strongly influences his or her immune responses to all related flu viruses encountered latermay explain the partial protection that older people have against the pandemic H1N1 flu virus.
(CIDRAP News) Legal issues that came into play during the H1N1 flu pandemic provided a useful look at how laws can help ease the availability of the vaccine, but in some instances can work against immunization efforts, according to a legal expert who has analyzed events that unfolded over the past year.
(CIDRAP News) In the wake of a pandemic vaccine that came too little and too late to blunt the second wave of pandemic flu infections last fall, President Barack Obama's science advisory group today presented a set of recommendations on how to more quickly produce a vaccine in the face of another novel flu outbreak or other public health emergency.
(CIDRAP News) If the trajectory of public opinion during the H1N1 influenza pandemic is any guide, safety worries and doubts about the severity of the disease threat may cause a good share of the public to shun vaccination the next time a pandemic emerges, according to a review of 10 months' worth of polls.
(CIDRAP News) An influenza expert who formerly headed the World Health Organization's (WHO's) flu program and now works for Novartis has suggested developing a prepandemic vaccine to get the jump on the next flu pandemican idea that other experts are greeting with caution or skepticism.
(CIDRAP News) Two newly released studies conducted at the University of Utah confirm what many physicians suspected: The news of the start of the H1N1 pandemic in late April 2009 caused panicked parents to bring children to emergency departments in drovesbut what was driving those ER visits was not flu symptoms, but rather the fear of flu.